SCHEMBL22632227

SCHEMBL22632227

CNCCc1cc(=O)oc2cc(N)ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC18A1 P54219 1/20 0.59
▸ SLC18A2 Q05940 1/20 0.59
▸ ALDH1A1 P00352 6/20 0.55
▸ KDM4E B2RXH2 6/20 0.55
▸ GAA P10253 5/20 0.55
▸ HPGD P15428 3/20 0.55
▸ CASP1 P29466 2/20 0.55
▸ CASP7 P55210 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ GLA P06280 2/20 0.55
▸ CA12 O43570 1/20 0.55
▸ CA1 P00915 1/20 0.55
▸ CA9 Q16790 1/20 0.55
▸ HSD17B3 P37058 5/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ SRC P12931 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623257 0.85 SLC18A1 (0.52) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL22632226 0.84 MTNR1B (0.60) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL8594115 0.84 HSD17B3 (0.68) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL5138290 0.82 HSD17B3 (0.66) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL8597625 0.81 ALDH1A1 (0.70) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL24623284 0.81 SLC18A1 (0.48) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL22632229 0.81 SLC18A1 (0.50) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL22632087 0.81 CYP2D6 (0.76) ALDH1A1KDM4EGAAHPGDHSD17B10
SCHEMBL3127680 0.80 ALDH1A1 (0.64) SLC18A1SLC18A2ALDH1A1KDM4EGAA
SCHEMBL8593488 0.79 SRC (0.64) SLC18A1SLC18A2ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback